Innocan Pharma

Innocan Pharma

Innocan Pharma™ is a specialty pharmaceutical company, developing products that harness the unique properties of Cannabinoids combined with smart delivery products.

Innocan Parma IPO on September 26, 2019, symbol CSE – INNO

MANAGEMENT TEAM – Leverage the capabilities of leading Israeli pharmaceutical industry executives.
BREAKTHROUGH INNOVATION – R&D focused on cannabinoid delivery systems: Patent Pending novel platform enabling the injection of Cannabinoids.
ISRAEL – A global leader in medical cannabis research and innovation with 30 years R&D and medical patient access.
OUTSTANDING PRODUCTS – Patent Pending CBD integrated over the counter topical products and derma cosmetics
MULTI-BILLION DOLLAR MARKETS – Expected early revenues and market entry in Q2 2020

Close Menu